tlr ligand (InvivoGen)
Structured Review

Tlr Ligand, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 623 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tlr+ligands+fsl+1/FSL-1/pmc07137550-116-24-43
Average 97 stars, based on 623 article reviews
Images
1) Product Images from "Comparative Analysis of Cellular Immune Responses in Conventional and SPF Olive Baboons ( Papio anubis )"
Article Title: Comparative Analysis of Cellular Immune Responses in Conventional and SPF Olive Baboons ( Papio anubis )
Journal: Comparative Medicine
doi: 10.30802/AALAS-CM-19-000035
Figure Legend Snippet: Ex vivo induction of IFNγ production after stimulation by TLR ligand. PBMC isolated from female conventional and SPF baboons were stimulated with TLR ligands TLR1, TLR5, TLR6, TLR4, TLR3 and TLR8 for 24 h, and cells were evaluated in IFNγ ELISpot assays. P values were obtained by using the Student t test; data are presented as mean ±SEM (n = 5). Differences were considered significant at ** P < 0.05, ***, P < 0.005, ****, P < 0.0002 .
Techniques Used: Ex Vivo, Isolation, Enzyme-linked Immunospot
Related Articles
Transfection:Article Title: Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice Article Snippet: The TLR ligands FSL-1 (TLR2/6), Poly I∶C (TLR3), Pam 3 CSK 4 (TLR1/2), Luciferase:Article Title: Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice Article Snippet: The TLR ligands FSL-1 (TLR2/6), Poly I∶C (TLR3), Pam 3 CSK 4 (TLR1/2), Control:Article Title: Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice Article Snippet: The TLR ligands FSL-1 (TLR2/6), Poly I∶C (TLR3), Pam 3 CSK 4 (TLR1/2), Plasmid Preparation:Article Title: Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice Article Snippet: The TLR ligands FSL-1 (TLR2/6), Poly I∶C (TLR3), Pam 3 CSK 4 (TLR1/2), Activity Assay:Article Title: Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice Article Snippet: The TLR ligands FSL-1 (TLR2/6), Poly I∶C (TLR3), Pam 3 CSK 4 (TLR1/2), |
![Figure 2. Effect of <t>TLR</t> ligands and cytokines on monocyte PD-1H expression. a) Isolated monocytes were treated with the indicated <t>TLR</t> <t>ligands</t> <t>[TLR1/2:</t> <t>PAM3CSK4</t> (1 mg/ml), <t>TLR2:</t> HKLM (108 cells/ml), <t>TLR3:</t> Poly I:C (2 mg/ml), <t>TLR4:</t> LPS (200 ng/ml), <t>TLR5:</t> flagellin (1 mg/ml), <t>TLR6/2:</t> <t>FSL1</t> (0.5 mg/ml), <t>TLR7:</t> Imiquimod (2 mg/ml), <t>TLR8:</t> <t>ssRNA40</t> (2 mg/ml), <t>TLR9:</t> <t>ODN2006</t> (5 mM)] or cytokines (c) and examined for PD-1H expression by flow cytometry. The bar graphs and dose response curves represent data (mean6SD) from 3 replicates. * indicates p,0.05 (One way ANOVA followed by Tukey test). b,d) Dose dependent effect of TLRs and cytokines was determined on five different donors. Mean +/- SD for 5 donors is shown. doi:10.1371/journal.pone.0109103.g002](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_9955/pm25279955/pm25279955__page4_image1.jpg)